Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 3, 2012, Pages 544-547

  Zanotti Fregonara, Paolo ^a   Innis, Robert B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CARBON 11; CHOLINESTERASE; DOPAMINE 1 RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; OPIATE RECEPTOR; RACLOPRIDE C 11; RADIOISOTOPE; RADIOLIGAND; ROLIPRAM C 11; UNCLASSIFIED DRUG; WAY 100635 C 11;

AMINO ACID TRANSPORT; AMYLOID PLAQUE; CELL METABOLISM; DOSIMETRY; HAPLORHINI; HUMAN; LETTER; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION SAFETY;

ANIMALS; CARBON RADIOISOTOPES; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; SAFETY;

EID: 84859631823     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-2005-8     Document Type: Letter

References (40)

1. Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. Sixth International Radiopharmaceutical Dosimetry Symposium. Stelson AS, editor. Oak Ridge:Associated Universities; 1999. p. 705-716.
2. Sprague DR, Fujita M, Ryu YH, Liow JS, Pike VW, Innis RB. Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [(11)C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses. Nucl Med Biol 2008;35:493-500. (Pubitemid 351636478)
3. Brown AK, Fujita M, Fujimura Y, Liow J-S, Stabin M, Ryu YH, et al. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28, a PET radioligand to image inflammation. J Nucl Med 2007;48:2072-9. (Pubitemid 350232319)
4. NIH RSC report: improving informed consent for research radiation studies, 10/17/2001.
5. Gatley SJ. Estimation of upper limits on human radiation absorbed doses fromcarbon-11-labeled compounds. J Nucl Med 1993;34:2208-15. (Pubitemid 24002969)
6. Parsey RV, Belanger MJ, Sullivan GM, Simpson NR, Stabin MG, Van Heertum R, et al. Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans. J Nucl Med 2005;46:614-9. (Pubitemid 41716406)
7. Parsey RV, Sokol LO, Bélanger MJ, Kumar JS, Simpson NR, Wang T, et al. Amyloid plaque imaging agent [C-11]-6-OHBTA-1: biodistribution and radiation dosimetry in baboon. Nucl Med Commun 2005;26:875-80. (Pubitemid 41426549)
8. Thees S, Neumaier B, Glatting G, Deisenhofer S, von Arnim CA, Reske SN, et al. Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans. Nuklearmedizin 2007;46:175-80. (Pubitemid 47612281)
9. Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, et al. Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates. Nucl Med Commun 2004;25:737-42. (Pubitemid 38901693)
10. Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET. J Nucl Med 2004;45:1555-9. (Pubitemid 47618510)
11. Hines CS, Liow JS, Zanotti-Fregonara P, Hirvonen J, Morse C, Pike VW, et al. Human biodistribution and dosimetry of 11CCUMI-101, an agonist radioligand for serotonin-1a receptors in brain. PLoS One 2011;6:e25309.
12. NIMH/SNIDD tracer database initiative. http://pdsp.med.unc.edu/snidd/ Accessed 17 Mar 2011.
13. Terry GE, Hirvonen J, Liow JS, Seneca N, Tauscher JT, Schaus JM, et al. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography. Eur J Nucl Med Mol Imaging 2010;37:1499-506.
14. Liow JS, Kreisl W, Zoghbi SS, Lazarova N, Seneca N, Gladding RL, et al. P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys. J Nucl Med 2009;50:108-15.
15. Seneca N, Zoghbi SS, Liow JS, Kreisl W, Herscovitch P, Jenko K, et al. Human brain imaging and radiation dosimetry of 11CN-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein. J Nucl Med 2009;50:807-13.
16. Hirvonen J, Roivainen A, Virta J, Helin S, Någren K, Rinne JO. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Eur J Nucl Med Mol Imaging 2010;37:606-12.
17. Kumar A, Muzik O, Chugani D, Chakraborty P, Chugani HT. PETderived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults. J Nucl Med 2010;51:139-44.
18. Herscovitch P, Schmall B, Doudet D, Carson R, Eckelman WC. Biodistribution and radiation dose estimates for [C-11]raclopride. J Nucl Med 1997;38:224P.
19. Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, et al. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 2006;47:313-9. (Pubitemid 46780897)
20. Ribeiro MJ, Ricard M, Bourgeois S, Lièvre MA, Bottlaender M, Gervais P, et al. Biodistribution and radiation dosimetry of [11C] raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging 2005;32:952-8. (Pubitemid 41205667)
21. GrahamMM, Peterson LM, Muzi M, Graham BB, SpenceAM, Link JM, et al. 1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies. J Nucl Med 1998;39:1805-10. (Pubitemid 28473535)
22. Laymon CM, Mason NS, Frankle WG, Carney JP, Lopresti BJ, Litschge MY, et al. Human biodistribution and dosimetry of the D2/3 agonist 11C-N- propylnorapomorphine (11C-NPA) determined from PET. J Nucl Med 2009;50:814-7.
23. Treyer V, Streffer J, Ametamey SM, Bettio A, Bläuenstein P, Schmidt M, et al. Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. Eur J Nucl Med Mol Imaging 2008;35:766-70.
24. Thierens H, van Eijkeren M, Goethals P. Biokinetics and dosimetry for [methyl-11C]thymidine. Br J Radiol 1994;67:292-5.
25. Bullich S, Slifstein M, Passchier J, Murthy NV, Kegeles LS, Kim JH, et al. Biodistribution and radiation dosimetry of the glycine transporter-1 ligand (11)C-GSK931145 determined from primate and human whole-body PET. Mol Imaging Biol 2011;13:776-84.
26. Tolvanen T, Någren K, Yu M, Sutinen E, Havu-Aurén K, JyrkkiöS, et al. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport. Eur J Nucl Med Mol Imaging 2006;33:1178-84. (Pubitemid 44484474)
27. Liu N, Li M, Li X, Meng X, Yang G, Zhao S, et al. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans. J Nucl Med 2009;50:303-8.
28. Virta JR, Tolvanen T, Någren K, Bruck A, Roivainen A, Rinne JO. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation. J Nucl Med 2008;49:347-53. (Pubitemid 351355198)
29. Tolvanen T, Yli-Kerttula T, Ujula T, Autio A, Lehikoinen P, Minn H, et al. Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data. Eur J Nucl Med Mol Imaging 2010;37:874-83.
30. Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, et al. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nucl Med Commun 2009;30:314-8.
31. van der Veldt AA, Hendrikse NH, Smit EF, Mooijer MP, Rijnders AY, Gerritsen WR, et al. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients. Eur J Nucl Med Mol Imaging 2010;37:1950-8.
32. Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. J Nucl Med 2007;48:128-33. (Pubitemid 47555386)
33. Santens P, DeVos F, ThierensH, Decoo D, SlegersG, Dierckx RA, et al. Biodistribution and dosimetry of carbon-11-methoxyprogabidic acid, a possible ligand for GABA-receptors in the brain. J Nucl Med 1998;39:307-10. (Pubitemid 28114524)
34. Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlborn M, et al. Radiation dose estimates in humans for (11) C-acetate whole-body PET. J Nucl Med 2004;45:1233-6. (Pubitemid 47611670)
35. Nugent AC, Neumeister A, Drevets WC, Eckelman WC, Channing MA, Herscovitch P. Human biodistribution and dosimetry of the PET benzodiazepine receptor ligand [11C]flumazenil. J Nucl Med 2004;45(Suppl):434P.
36. Deloar HM, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M, et al. Estimation of internal absorbed dose of L-[methyl-11C] methionine using whole-body positron emission tomography. Eur J Nucl Med 1998;25:629-33. (Pubitemid 28297838)
37. O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, et al. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med 2009;50:309-15.
38. Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, et al. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand, (11)CNNC 112, in humans. J Nucl Med 2006;47:100-4. (Pubitemid 46768518)
39. Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, et al. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers. Nucl Med Biol 2007;34:465-70. (Pubitemid 46722682)
40. Marthi K, Hansen SB, Jakobsen S, Bender D, Smith SB, Smith DF. Biodistribution and radiation dosimetry of [N-methyl-11C]mirtazapine, an antidepressant affecting adrenoceptors. Appl Radiat Isot 2003;59:175-9. (Pubitemid 36993613)